发明名称 Compounds effecting glucokinase
摘要 <p>The invention relates to compounds of Formula (IIf) or a salt or solvate thereof, wherein R<3>, Het, X and Z<1> are as described in the specification, pharmaceutical compositions containing them, their use in the preparation of a medicament for the treatment or prevention of a disease condition mediated through glucokinase (GLK), such as type 2 diabetes, and methods for their preparation. <CHEM></p>
申请公布号 SI1568367(T1) 申请公布日期 2007.08.31
申请号 SI20020030559T 申请日期 2002.08.15
申请人 ASTRAZENECA AB 发明人 JOHNSTONE CRAIG;JAMES ROGER;MCKERRECHER DARREN;BOYD SCOTT;CAULKETT PETER;HARGREAVES RODNEY;JONES CLIFFORD DAVID;BOWKER SUZANNE;BLOCK MICHAEL HOWARD
分类号 A61K31/165;A61K31/167;A61K31/192;A61K31/195;A61K31/341;A61K31/415;A61K31/4155;A61K31/42;A61K31/425;A61K31/426;A61K31/427;A61K31/428;A61K31/433;A61K31/44;A61K31/4402;A61K31/4436;A61K31/4439;A61K31/444;A61K31/445;A61K31/454;A61K31/455;A61K31/496;A61K31/4965;A61K31/497;A61K31/50;A61K31/501;A61K31/505;A61K31/506;A61K31/5377;A61P3/04;A61P3/06;A61P3/10;A61P43/00;C07D213/75;C07D213/76;C07D213/82;C07D213/85;C07D231/40;C07D233/48;C07D237/20;C07D237/24;C07D239/42;C07D239/47;C07D241/20;C07D241/26;C07D241/28;C07D261/14;C07D277/20;C07D277/46;C07D277/54;C07D277/56;C07D277/58;C07D277/82;C07D285/12;C07D285/135;C07D307/66;C07D307/68;C07D401/04;C07D403/04;C07D405/12;C07D409/12;C07D409/14;C07D413/04;C07D413/12;C07D413/14;C07D417/04;C07D417/12;C07D417/14 主分类号 A61K31/165
代理机构 代理人
主权项
地址